ReviewFrontiers in microbiology2026
Protein aggregation as a bistable switch in bacterial cell fate: from adaptive dormancy to cytotoxic death.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein aggregation has traditionally been considered a hallmark of proteostasis disruption and cellular dysfunction. However, recent studies have revealed that bacterial protein aggregation is not merely a passive consequence of stress-induced damage but may represent a dynamic component of cellular adaptation. Under adverse conditions, reversible protein condensation and aggregation have been associated with bacterial dormancy, persistence, and the viable but non-culturable (VBNC) state, whereas excessive and irreversible aggregation may contribute to loss of cellular function and bacterial death. Nevertheless, whether protein aggregation serves as a primary determinant of bacterial cell fate or reflects a consequence of broader physiological changes remains an important unresolved question. In this review, we summarize current advances in understanding bacterial protein aggregation, including the roles of liquid-liquid phase separation (LLPS), protein quality control systems, ATP-dependent proteostasis regulation, and aggregate maturation. We discuss how stress-induced alterations in proteostasis networks influence bacterial survival, aging, persistence, and antibiotic tolerance. Available evidence supports a working model whereby the physicochemical properties of protein aggregates may dictate ultimate bacterial cell fate. Nevertheless, the causal link between condensate phase behavior, aggregate material characteristics, and cell fate decisions remains to be thoroughly validated, even though emerging technologies including live single-molecule cell imaging and quantitative analytical tools have greatly advanced our mechanistic understanding of the dynamic progression of bacterial protein aggregation. Finally, we discuss the therapeutic potential and challenges of targeting bacterial proteostasis and aggregation pathways to combat persistent and multidrug-resistant pathogens. A deeper mechanistic understanding of how protein aggregation balances adaptation and toxicity may reveal new vulnerabilities within bacterial survival strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.